<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cryopyrin-associated <z:e sem="disease" ids="C0585274" disease_type="Disease or Syndrome" abbrv="">periodic syndromes</z:e> are categorized as a spectrum of three autoinflammatory diseases, namely familial cold auto-inflammatory syndrome, <z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> infantile neurological cutaneous articular syndrome </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> are caused by mutations in the NLRP3 gene coding for cryopyrin and result in active interleukin-1 release: their rarity and shared clinical indicators involving skin, joints, central <z:mp ids='MP_0008912'>nervous</z:mp> system and eyes often mean that correct diagnosis is delayed </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003674'>Onset</z:hpo> occurs early in childhood, and life-long therapy with interleukin-1 blocking agents usually leads to tangible clinical remission and inflammatory marker normalization in a large number of patients, justifying the need to facilitate early diagnosis and thus avoid irreversible negative consequences for tissues and organs </plain></SENT>
</text></document>